Concord Drugs Limited

Concord Drugs Limited (NSE/BSE: CONCORD) is an Indian publicly listed company quoted on the Bombay Stock Exchange (BSE). The company operates in healthcare, a sector that combines regulated pricing with long-run demand growth from a rising domestic patient base. Its securities trade under ISIN INE858L01010. As of the most recent update, Concord Drugs Limited carries an equity market capitalisation of approximately ₹39.21 Cr, which places it among the tracked constituents of the Healthcare sector on Indian exchanges. Detailed shareholding-pattern disclosures are published quarterly by Concord Drugs Limited via stock-exchange filings. For investors and researchers tracking healthcare listings, CONCORD provides a window into how listed Indian capital is being allocated within the sector — by promoters, by foreign institutions, and by retail participants. This page consolidates Concord Drugs Limited's core registration, listing and shareholding data into a single open record. Figures are refreshed weekly from the official NSE archives and BSE scrip master; the company's own filings remain the authoritative source for governance, financial and disclosure data.